208 related articles for article (PubMed ID: 25947573)
1. ⁹⁹mTc-3PRGD₂ SPECT to monitor early response to neoadjuvant chemotherapy in stage II and III breast cancer.
Ji B; Chen B; Wang T; Song Y; Chen M; Ji T; Wang X; Gao S; Ma Q
Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1362-70. PubMed ID: 25947573
[TBL] [Abstract][Full Text] [Related]
2. (99m)Tc-3PRGD2 SPECT/CT Imaging for Monitoring Early Response of EGFR-TKIs Therapy in Patients with Advanced-Stage Lung Adenocarcinoma.
Zhang Z; Zhao X; Ding C; Wang J; Zhang J; Wang F
Cancer Biother Radiopharm; 2016 Sep; 31(7):238-45. PubMed ID: 27563805
[TBL] [Abstract][Full Text] [Related]
3. (99m)Tc-3PRGD 2 SPECT/CT predicts the outcome of advanced nonsquamous non-small cell lung cancer receiving chemoradiotherapy plus bevacizumab.
Ma Q; Min K; Wang T; Chen B; Wen Q; Wang F; Ji T; Gao S
Ann Nucl Med; 2015 Jul; 29(6):519-27. PubMed ID: 25911312
[TBL] [Abstract][Full Text] [Related]
4. Comparison of [
Chen Z; Fu F; Li F; Zhu Z; Yang Y; Chen X; Jia B; Zheng S; Huang C; Miao W
Mol Imaging Biol; 2018 Oct; 20(5):846-856. PubMed ID: 29497956
[TBL] [Abstract][Full Text] [Related]
5. Advantages of
Lv N; Gao S; Bai L; Ji B; Xue J; Ge X; Chen B
Ann Nucl Med; 2019 Jan; 33(1):39-46. PubMed ID: 30218281
[TBL] [Abstract][Full Text] [Related]
6. [
Zheng S; Chen Z; Huang C; Chen Y; Miao W
Ann Nucl Med; 2019 Feb; 33(2):135-143. PubMed ID: 30392070
[TBL] [Abstract][Full Text] [Related]
7. Clinical Value of
Gao R; Zhang GJ; Wang YB; Liu Y; Wang F; Jia X; Liang YQ; Yang AM
Sci Rep; 2018 Jan; 8(1):473. PubMed ID: 29323252
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of (99m)Tc-3PRGD2 scintimammography for differentiation of malignant from benign breast lesions: Comparison of visual and semi-quantitative analysis.
Chen Q; Xie Q; Zhao M; Chen B; Gao S; Zhang H; Xing H; Ma Q
Hell J Nucl Med; 2015; 18(3):193-8. PubMed ID: 26574690
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Tc-99m-3PRGD2 Integrin Receptor Imaging in the Differential Diagnosis of Breast Lesions and Comparison With Mammography.
Chen G; Ouyang Z; Wang F; Wu H; Jia B; Chordia MD
Cancer Invest; 2017 Feb; 35(2):108-115. PubMed ID: 28135863
[TBL] [Abstract][Full Text] [Related]
10. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
Sergieva SB; Timcheva KV; Hadjiolov ND
J BUON; 2006; 11(1):61-8. PubMed ID: 17318954
[TBL] [Abstract][Full Text] [Related]
11. Integrin Imaging with
Jin X; Liang N; Wang M; Meng Y; Jia B; Shi X; Li S; Luo J; Luo Y; Cui Q; Zheng K; Liu Z; Shi J; Li F; Wang F; Zhu Z
Radiology; 2016 Dec; 281(3):958-966. PubMed ID: 27479638
[TBL] [Abstract][Full Text] [Related]
12. 99mTc-3PRGD2 for integrin receptor imaging of lung cancer: a multicenter study.
Zhu Z; Miao W; Li Q; Dai H; Ma Q; Wang F; Yang A; Jia B; Jing X; Liu S; Shi J; Liu Z; Zhao Z; Wang F; Li F
J Nucl Med; 2012 May; 53(5):716-22. PubMed ID: 22499615
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of
Wu Y; Wang Y; Yang Z; Teng C; Guo Z
Thorac Cancer; 2022 Nov; 13(21):3025-3031. PubMed ID: 36104010
[TBL] [Abstract][Full Text] [Related]
14. Utility of Tc-PEG4-E[PEG4-c(RGDfK)]2 in Posttherapy Surveillance of Patients with Reelevated Carcinoembryonic Antigen Levels.
Gao R; Zhang G; Chen L; Zhu Z; Wang F; Yang A
Med Princ Pract; 2015; 24(3):244-9. PubMed ID: 25871432
[TBL] [Abstract][Full Text] [Related]
15. (99m)Tc-3P-RGD2 SPECT to monitor early response to bevacizumab therapy in patients with advanced non-small cell lung cancer.
Chen B; Zhao G; Ma Q; Ji B; Ji T; Xin H; Gao S
Int J Clin Exp Pathol; 2015; 8(12):16064-72. PubMed ID: 26884883
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of
Zheng J; Miao W; Huang C; Lin H
Ann Nucl Med; 2017 Jul; 31(6):486-494. PubMed ID: 28474165
[TBL] [Abstract][Full Text] [Related]
17. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
[TBL] [Abstract][Full Text] [Related]
18. Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings.
Collarino A; de Koster EJ; Valdés Olmos RA; de Geus-Oei LF; Pereira Arias-Bouda LM
Clin Breast Cancer; 2018 Feb; 18(1):9-18. PubMed ID: 28728876
[TBL] [Abstract][Full Text] [Related]
19. The usefulness of Tc-99m-tetrofosmin SPECT/CT in the detection of residual tumors and axillary lymph node metastases in breast cancer patients following neoadjuvant therapy.
Spanu A; Sanna D; Chessa F; Farris A; Nuvoli S; Madeddu G
Clin Nucl Med; 2011 Nov; 36(11):997-1002. PubMed ID: 21975387
[TBL] [Abstract][Full Text] [Related]
20. Scintimammography using Tc-99m tetrofosmin.
Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I
Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]